9-34459027-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012144.4(DNAI1):​c.22G>T​(p.Ala8Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0616 in 1,613,884 control chromosomes in the GnomAD database, including 3,592 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A8P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.050 ( 271 hom., cov: 32)
Exomes 𝑓: 0.063 ( 3321 hom. )

Consequence

DNAI1
NM_012144.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.40

Publications

24 publications found
Variant links:
Genes affected
DNAI1 (HGNC:2954): (dynein axonemal intermediate chain 1) This gene encodes a member of the dynein intermediate chain family. The encoded protein is part of the dynein complex in respiratory cilia. The inner- and outer-arm dyneins, which bridge between the doublet microtubules in axonemes, are the force-generating proteins responsible for the sliding movement in axonemes. The intermediate and light chains, thought to form the base of the dynein arm, help mediate attachment and may also participate in regulating dynein activity. Mutations in this gene result in abnormal ciliary ultrastructure and function associated with primary ciliary dyskinesia and Kartagener syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
DNAI1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016712248).
BP6
Variant 9-34459027-G-T is Benign according to our data. Variant chr9-34459027-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 178761.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0634 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAI1NM_012144.4 linkc.22G>T p.Ala8Ser missense_variant Exon 1 of 20 ENST00000242317.9 NP_036276.1 Q9UI46-1A0A140VJI0
DNAI1NM_001281428.2 linkc.22G>T p.Ala8Ser missense_variant Exon 1 of 20 NP_001268357.1 Q9UI46A0A087WWV9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAI1ENST00000242317.9 linkc.22G>T p.Ala8Ser missense_variant Exon 1 of 20 1 NM_012144.4 ENSP00000242317.4 Q9UI46-1
DNAI1ENST00000614641.4 linkc.22G>T p.Ala8Ser missense_variant Exon 1 of 20 5 ENSP00000480538.1 A0A087WWV9
DNAI1ENST00000437363.5 linkc.22G>T p.Ala8Ser missense_variant Exon 1 of 9 5 ENSP00000395396.1 Q5T8G8
DNAI1ENST00000470982.5 linkn.47+1567G>T intron_variant Intron 1 of 4 5

Frequencies

GnomAD3 genomes
AF:
0.0496
AC:
7547
AN:
152090
Hom.:
271
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0133
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.0460
Gnomad ASJ
AF:
0.0473
Gnomad EAS
AF:
0.00789
Gnomad SAS
AF:
0.0448
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0651
Gnomad OTH
AF:
0.0392
GnomAD2 exomes
AF:
0.0550
AC:
13820
AN:
251398
AF XY:
0.0558
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.0439
Gnomad ASJ exome
AF:
0.0416
Gnomad EAS exome
AF:
0.00674
Gnomad FIN exome
AF:
0.115
Gnomad NFE exome
AF:
0.0625
Gnomad OTH exome
AF:
0.0611
GnomAD4 exome
AF:
0.0629
AC:
91923
AN:
1461676
Hom.:
3321
Cov.:
31
AF XY:
0.0627
AC XY:
45619
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.00995
AC:
333
AN:
33480
American (AMR)
AF:
0.0443
AC:
1981
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0419
AC:
1095
AN:
26136
East Asian (EAS)
AF:
0.00491
AC:
195
AN:
39700
South Asian (SAS)
AF:
0.0532
AC:
4586
AN:
86252
European-Finnish (FIN)
AF:
0.112
AC:
6002
AN:
53416
Middle Eastern (MID)
AF:
0.0331
AC:
191
AN:
5768
European-Non Finnish (NFE)
AF:
0.0667
AC:
74126
AN:
1111814
Other (OTH)
AF:
0.0565
AC:
3414
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
4568
9136
13705
18273
22841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2726
5452
8178
10904
13630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0496
AC:
7546
AN:
152208
Hom.:
271
Cov.:
32
AF XY:
0.0505
AC XY:
3758
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0133
AC:
552
AN:
41546
American (AMR)
AF:
0.0461
AC:
704
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0473
AC:
164
AN:
3470
East Asian (EAS)
AF:
0.00772
AC:
40
AN:
5184
South Asian (SAS)
AF:
0.0448
AC:
216
AN:
4822
European-Finnish (FIN)
AF:
0.118
AC:
1251
AN:
10602
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0650
AC:
4422
AN:
67980
Other (OTH)
AF:
0.0393
AC:
83
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
363
726
1090
1453
1816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0488
Hom.:
306
Bravo
AF:
0.0413
TwinsUK
AF:
0.0693
AC:
257
ALSPAC
AF:
0.0701
AC:
270
ESP6500AA
AF:
0.0182
AC:
80
ESP6500EA
AF:
0.0630
AC:
542
ExAC
AF:
0.0540
AC:
6553
Asia WGS
AF:
0.0220
AC:
78
AN:
3478
EpiCase
AF:
0.0614
EpiControl
AF:
0.0563

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:4
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala8Ser in exon 1 of DNAI1: This variant is not expected to have clinical signif icance because it has been identified in 6.3% (542/8600) of European American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs11547035). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
9.7
DANN
Benign
0.79
DEOGEN2
Benign
0.0076
T;T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.090
N
LIST_S2
Benign
0.32
T;T;T
MetaRNN
Benign
0.0017
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
.;.;N
PhyloP100
2.4
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.44
.;N;N
REVEL
Benign
0.16
Sift
Benign
0.40
.;T;T
Sift4G
Benign
0.70
T;T;T
Polyphen
0.0020
.;.;B
Vest4
0.080
MPC
0.10
ClinPred
0.012
T
GERP RS
2.6
PromoterAI
0.0057
Neutral
Varity_R
0.043
gMVP
0.093
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11547035; hg19: chr9-34459025; API